Subscribe To
quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et
ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) — quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Comp...
November 3, 2023, 12:41 pm
quoin pharmaceuticals announces third quarter 2023 financial results and corporate update conference call to be held on thursday november 9th at 8:30 am et
ASHBURN, Va., Nov. 03, 2023 (GLOBE NEWSWIRE) -- quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Compa...
November 3, 2023, 8:41 am
quoin pharmaceuticals, ltd. (qnrx) q2 2023 earnings call transcript
quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX ) Q2 2023 Results Earnings Conference Call August 3, 2023 8:30...
August 7, 2023, 1:24 am
quoin pharmaceuticals provides corporate update and announces second quarter 2023 financial results
Company reports positive clinical data for first subject to complete testing in ongoing open-label Netherton Syndrome study Subject’s skin was asses...
August 2, 2023, 8:45 pm
Why is quoin pharmaceuticals (qnrx) stock down 90% today?
quoin Pharmaceuticals (NASDAQ: QNRX ) stock is taking a massive beating on Monday as the company prepa...
July 17, 2023, 8:18 am
quoin pharmaceuticals provides corporate update and announces first quarter 2023 financial results
First patient dosed in quoin’s single arm, open label clinical trial in Netherton Syndrome patients c...
May 8, 2023, 9:00 pm
quoin pharmaceuticals provides corporate update and announces fourth quarter and full year 2022 financial results
quoin announced dosing of first patient in double blinded clinical study to evaluate QRX003 for Nethert...
March 8, 2023, 10:08 pm
Akebia therapeutics and 20 stocks moving premarket
Gainers quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dr...
July 1, 2022, 7:01 am
Why quoin pharmaceuticals stock is trading higher
quoin Pharmaceuticals (NASDAQ: QNRX) shares are trading higher Monday after the company announced it re...
April 25, 2022, 11:45 am